LOLA RODGERS: Open Payments
NPI 1598284762 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 34 payments from 14 companies in 2025. Trend: 2023 $646 · 2024 $1,190 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $147 |
| Viatris Specialty LLC | 4 | $111 |
| Lilly USA, LLC | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Novo Nordisk Inc | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| UCB, Inc. | 1 | $25 |
Products named: AIRSUPRA, YUPELRI, JARDIANCE, REXULTI, AUSTEDO XR, Kerendia, MOUNJARO, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
